2025 POSTER PRESENTATIONS
Preliminary list as of April 16
2bind GmbH
The Format Matters: Stabilities of Bispecifics
A-Alpha Bio
Engineering High-Affinity, Developable Antibodies with AlphaBind – A Deep Learning Affinity Oracle
A-Alpha Bio
Large-Scale Evaluation of Inverse Folding Models for De Novo Antibody Design Using High-Throughput Binding Affinity Assays
A-Alpha Bio
Rapid Development of Dual Specific Antibodies via Platform Integration
AAX Biotech AB
Seqitope: High-Resolution, High-Throughput Epitope Mapping Supporting Affinity Maturation Strategies
Abalone Bio
CB2 Specific Antibody Agonists for Treatment of CIPN and Liver Fibrosis
AbbraTech, Inc.
Innovative Platform for Functional Antibody Discovery Against Challenging Membrane Protein Targets
AbbraTech, Inc.
Streamlining Antibody Discovery: Rational Libraries, Targeted Mutagenesis, High-Resolution Screening, and Recombineering
AbCellera
Strategies for Tailoring T-Cell Engager Design for Solid Tumor Indications
Ability Biologics
AbiLeap™: Systematically Generate Conditionally Active Biotherapeutics
Absolute Biotech
Comparing Potential Bispecific Formats of Trastuzumab and a Humanized OKT3
Absolute Biotech
Prometheus 2.0™: Engineering Manufacturable Humanized Antibodies from Diverse Sources Including Rabbit and Camelid Antibodies
Academia Sinica
Identification of Tumor-Specific Antibody Using CAR-Based Cell Display System
Adimab LLC
Generation of CD28 Costimulatory Heavy Chain-Only Antibodies Using a Synthetic, Yeast-Based Platform for Their Discovery and Engineering
Affinité Instruments
A Simple SPR Solution for Complex Samples
Ailux Biologics by XtalPi
Accurate Prediction of Antibody-Antigen and Protein-Protein Complex Structure Accelerates Next-Gen Biologics Development
Ailux Biologics by XtalPi
De-Risking and Accelerating the Discovery of High-Value Antibodies Through AI-Driven Active Learning and High-Throughput Humanization
Ailux Biologics by XtalPi
Enhancing TCR Affinity and Maintaining pMHC Specificity Through Structure-Guided Mutagenesis and Yeast Display Screening
Ajinomoto Co., Inc.
Accelerating Novel Drug Modality Development by AJICAP® Site-Specific Chemical Conjugation Technology
Ajinomoto Co., Inc.
Corynex® for Next-Generation Biologics: ncAA Incorporation Enables Versatile VHH Conjugation
Ajinomoto Co., Inc.
Expanding Therapeutic Windows of ADCs Enabled by AJICAP® Site-Specific Chemical Conjugation and Hydrophilic Linker Technology
Alcyomics Ltd.
Skimune®: An In Vitro Human Skin Platform for Immunotoxicity Testing of Novel Therapeutics
Ampersand Biomedicines
A VEGF / 4-1BB Bifunctional Therapeutic Couples VEGF Binding to Allosteric 4-1BB Activation, Programming Robust Innate and Adaptive Antitumor Immunity
Antibody Design Labs
Super Naïve OPAL Libraries™: A New Tool for Rapid VHH Discovery
Apoha Ltd.
High-Throughout Screening of Antibody Developability Properties Using a Neuromorphic Sensing Platform
Apoha Ltd.
Unifying Sequence, Structure and State Data: A Digital Platform for Data Integration and Antibody Engineering
Applied Photophysics, Inc.
Automating Protein Stability Screening: Enhancing Throughput and Accuracy with SUPR-DSF
Applied Photophysics, Inc.
Complete Thermal Melting Characterization of the NISTmAb with the SUPR-DSF Microplate Reader
Applied Photophysics, Inc.
Sensitive Circular Dichroism Analysis of Therapeutic Antibodies
Applied StemCell
Strategies for Engineering Mammalian Cells to Express Difficult Proteins — 4-6 Weeks from Start to Final Clone or Pool CELL LINE ENG
Asimov, Inc.
Advancing a Polar Metabolomics Workflow Towards Enhancing Therapeutic Protein Expression and Modulating Quality Attributes
ATUM
Leap-In Transposase®: High Yield Stable Cell Lines with Predictable Antibody Quality and Improved Expression Stability
Auburn University
Developing a Predictive Model for ΔΔG in Protein-Peptide Binding
Auburn University
EPPI_ddg: Predicting Changes in Binding Free Energy from Point Mutations Using a Structure Based Feature Space and Random Forest
Aurigene Pharmaceutical Services
High Efficiency B-Cell Culturing Platform for Rapid Antibody Discovery
Avenue Biosciences
High-Throughput Engineering of Signal Peptides to Maximize Protein Expression
Bayer CropScience
Purification Strategies for Transmembrane Proteins Sp1 and Sp2 for Safety Evaluation
Be Biopharma, Inc.
CRISPR/Cas9-Based Precision B Cell Gene Engineering Coupled with Artificial Intelligence-Guided Protein Design Produces Active Tissue Nonspecific Alkaline Phosphatase for the Treatment of Hypophosphatasia
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
BCG027: A Novel Bispecific Antibody-Drug Conjugate Targeting SEZ6 and B7-H3 for Small Cell Lung Cancer
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
BCG028: A Novel Fc-Engineered Biparatopic OX40 Antagonist for Targeted Treatment of Atopic Dermatitis
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
RenNano®-Derived Human Heavy-Chain-Only TFR1 Antibodies Enable Efficient Blood-Brain Barrier Penetration and Therapeutic Delivery
BioDlink (TOT BIOPHARM)
GL-DisacLink:A Promising Technology for Glycosite-Specific Conjugation
Biointron
A Proven and Reliable Alpaca VHH Antibody Discovery Platform
Biointron
Simplified and Humanized: Empowering Humanized Antibody Discovery with AbDrop™ Solution
Bio-Rad Laboratories
Extracellular Vesicle Isolation and Analysis
Bio-Rad Laboratories
Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform
Bio-Rad Laboratories
Rapid Generation of Bispecific Antibodies for High Throughput Screening with SpyLock Technology
Bio-Rad Laboratories
TrailBlazer: A Rapid Modular Antibody Assembly Platform
Biotage US
Elevating Protein Purification Efficiency: Transitioning from Manual Techniques to Automated Platforms
Bio-Techne
Accelerated Assessment of AAV Titer, Quality, Potency with Automated Analytical Tools
Bio-Techne
Biotherapeutic Charge Variant Fractionation Using MauriceFlex™
Bio-Techne
Custom Workflows Accelerate Immunoassay Development with High-Content Biophysics and Modeling
Bio-Techne
Engineering Cell and Gene Therapy Reagents
BIOVIA, a Dassault Systèmes Company
In Silico Affinity Maturation of Antibodies via Physics-Based Virtual Mutagenesis
Bioworkshops
Asymmetric bsAbs: A Reliable Platform Solution
Boehringer Ingelheim
Optimization of Plate Based CHO Expression and Protein A Purification Technologies to Support Early-Stage Biotherapeutic Discovery
BPS Bioscience
Empowering the Development of TCR-T Cells for Adoptive Cell Therapy
BPS Bioscience
Enabling Research Tools for αß and γδ T Cell-Based Immunotherapy
Broad Institute of MIT and Harvard
Rapid, Automated Discovery of VHH Binders with Diverse Epitopes and Affinities
Brown University
Characterization of Antibody-Based Therapeutics Using Charge-Based and Sized Based Microfluidic Electrophoresis
Bruker Biosensors
Accelerating Biologics Discovery with Comprehensive Biophysical Characterizations of Binding Kinetics
Bruker Cellular Analysis
Accelerating Internalizing Antibody Discovery with Bruker Cellular Analysis Optofluidic Platforms
Bruker Cellular Analysis
Cryopreservation of Activated Memory B Cells Facilitates Enhanced Flexibility and Throughput for Opto® B Discovery on the Beacon® Optofluidic Systems
Carterra
Full Antigen Kinetics of Fabs Directly from Crude Periplasmic Extracts on an Anti-CH1 Capture Surface
Carterra
HT-SPR Evaluation of Fc Gamma Receptor Binding Using Carterra LSAXT
Charles River Laboratories
Developing an mRNA-Encoded Antibody Platform to Accelerate Therapies to Clinic
Charles River Laboratories
Generation of a B7-H3 Knock Out Cell Line: Validation for Off-Target Screening Using the Retrogenix® Cell Microarray Platform
Chemical Computing Group
Pharmacophore-Guided Virtual Screening of Antibody Formats
Chemical Computing Group
Structure-Based Charge Calculations for Predicting Properties and Profiling Antibody Therapeutics
Chulalongkorn University
Production of Starch-Modifying Enzymes
ClimbBio
A Tunable and Scalable Platform for Precise Fucosylation Control to Enhance Efficacy of Therapeutic Antibodies: Application to Clinical Manufacturing of Budoprutug
CompleCure, Inc.
Development of a New ADC Platform Designed by Antibody Mimetic Drug Conjugate
Conigen Bioscience
Engineered Immune Checkpoint CD28 and CTLA-4 Homodimer Proteins Demonstrate Potent Binding Affinities to Their Ligand CD80
Conigen Bioscience
Engineered Novel CD155 and Nectin-4 Homodimer Proteins Dramatically Enhance Binding Affinities to Their Receptor TIGIT Compared to Respective Monomers
Conigen Bioscience
Novel Soluble Cytokine Receptors IFNγR1 Homodimer and IFNαR1/R2 Heterodimer Enhance Binding to Type II and Type I Interferons Compared to Monomers
Conigen Bioscience
Recombinant G-Protein Coupled Chemokine Receptors CXCR4 and CXCR5 on Nanoparticles are Bioactive, Binding to the Chemokine Ligands
CovalX Instruments, Inc.
Recombinant Expression Validates De Novo Sequencing Accuracy: Trastuzumab and Anti-Factor XII Case Study
Cube Biotech GmbH
A New Era in Drug Development Targeting the Most Pivotal Class of Proteins – Introducing an Automated Platform for the Solubilization and Purification of Membrane Proteins
Curia
Optimized Transient Production: Faster Preclinical Studies with Enhanced Quality Control
Curia
Rapid Discovery of Antagonistic Human/Cyno CD200R1 Llama VHH Nanobodies Using Single B Cell Technology
Cytiva
Advanced Injection Tools Enable the Study of Complex Biological Processes
Daegu Gyeongbuk Institute of Science and Technology
Modular and Nondisturbing Chimeric Adaptor Protein for Surface Chemistry of Small Extracellular Vesicles
Dapu Biotechnology Co., Ltd. (DPBIO)
High-Performance Antibody Discovery Using DPBIO CytoSpark Microfluidic Droplet Sorting System
Deeptope
Epitope Mapping Case Studies by Deep Mutational Scanning
Deeptope
Modulation of Antibodies' Fc Fragment Interaction with Fc Receptors by Deep Mutational Scanning
Demeetra AgBio
Unveiling the Complementary Benefits of Cas-CLOVER Dimeric Nuclease and Harbor-IN License Free Transposase
Depth Charge SAS
Covalently Controlled Conditional Immunocytokine Cancer Therapy; Silent in the Periphery, Super Active in the Tumor
DIMA Biotech
Therapeutic mAb Discovery for Multi-Pass Transmembrane Protein Targets
Domainex Ltd.
Integral Membrane Proteins for Biophysics and Cryo-EM Applications – Case Study of the Ion Channel TrpML3
Dotmatics
Antibody and Therapeutics Discovery: Network and Tree Visualizations for Interrogating Sequence Similarity Between Unique Clones and CDRs in NGS Datasets
Elasmogen Ltd.
Characterization of a Bi-Functional soloMER® Drug Conjugate (SDC) Targeting TNFa and JAK Enzymes with a Neutrophil Elastase-Cleavable Linker for Inflammation-Site Specific Payload Release
Enrich Biosystems, Inc.
B Cell Screening Using TroVo
Eukarys SAS
Artificial Expression System for High-Performance Production of Biomedicines: From Concepts to Reality
Eurofins DiscoverX
Quantitative Measurement of Fc-Mediated ADCC & ADCP Activity of Therapeutic Antibodies Using a Robust, Universal Cell-Based Assay Platform
Eurofins DiscoverX
Unlocking Agonism: A Comprehensive Strategy to Characterize Agonistic Antibodies for Immunotherapy & Autoimmunity
FairJourney Biologics
Bioinformatics at FairJourney Biologics: Antibody In Silico Risk Assessment (ISRA)
FairJourney Biologics
From Binding to Biology: Dissecting Fc–FcRn Interactions to Drive Antibody Half-Life Design
Fluidic Sciences Ltd.
Machine Learning Guided Interaction Analysis
Fortis Life Sciences
Cell-Apalooza: An Anti-T-Cell Immunization Strategy for a Novel, Targeted “AbNano™” Immune-Derived Library
FUJIFILM Irvine Scientific
Chemically Defined BalanCD HEK293 Viral Feed Boosts Viral Vector Production
FUJIFILM Irvine Scientific
Demonstrating Key Processes of the T Cell Therapy Workflow in Chemically Defined Media
Fusion Antibodies PLC
A Rational Affinity Maturation Platform (RAMP™ )
Fusion Antibodies PLC
Mammalian Display for Antibody Discovery
Galux, Inc.
Precise, Specific, and Sensitive De Novo Antibody Design Across Multiple Cases
Gator Bio
High-Throughput (HTP) Label-Free Kinetics Screening Using Gator-Pro in Early Single Domain Antibody Discovery: A Comparative Analysis with Phage Display Samples from Periplasma
Genedata AG
A Digital Platform for the Development of Next-Generation Antibody Drug Conjugates (ADCs) and Other Antigen-Targeting Conjugates
Genedata AG
Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development
Genedata AG
An Automated High Throughput Engineering Platform for AI-Supported Developability Predictions
Genedata AG
Fully Automated Candidate Creation Workflow for Intact Mass Mapping of Oligonucleotide Therapeutics
Genedata AG
Integrated Analysis of Assays Drive Early Developability Assessment of Antibodies
Genentech
A Novel Modular Platform for Conditional Cytokine Activation
Genentech
Modulation of the High Concentration Viscosity of IgG[1] Antibodies Using Clinically Validated Fc Mutations
GENEWIZ from Azenta Life Sciences
Accelerating Antibody Discovery: High-Throughput Solutions for Producing Antibodies at Scale
GENEWIZ from Azenta Life Sciences
Revolutionizing Antibody Therapeutics: Harnessing Machine Learning for Bispecific Antibody Discovery
GenNext Technologies, Inc.
High-Throughput Protein Structural Analysis with the AutoFox® System: Automated HRPF for Biotherapeutic Insight
Gensaic
The FORGE™ Engine Uncovers Tissue-Targeting Moieties for Delivery of Oligonucleotide Therapeutics
Georgia Institute of Technology
Engineering a Next-Generation CRISPR-Repressor for Highly Optimized Cancer Gene Regulation
Ginkgo Bioworks
A High-Throughput Antibody Developability Data Generation Platform for AI/ML Model Training and Drug Discovery
Ginkgo Bioworks
Predicting and Generating Developable Antibodies with Protein Language Models
Glykos Finland Ltd.
Hydrophilic Stabilized Glycopeptide Linker Enables Novel Topoisomerase 1 Inhibitor and Dual-Payload ADCs
GSK
Function First Screening Approaches in Antibody Discovery Using the Beacon® Optofluidic System
Harvard University
AminoX: Multiplexed Transformation of De Novo Minibinders into Covalent Biologics with User-Defined Non-standard Amino Acids and mRNA Display
Harvard University
De Novo Designed Covalent Minibinders for CTLA-4 Blockade
i3 Membrane Corporation
Digital Membrane Chromatography
Illimis Therapeutics
Therapeutic Potential of Novel GAS6-Mediated Anti-Inflammatory Adaptor (GAIA): Overcoming Neuroinflammation via Efferocytosis in Anti-Aß Immunotherapies
ImmuneSpec
High-Sensitive Immunopeptidomics for Identification of Neoantigens and Validation of MHC Presentation of (Predicted) Antigens
ImmuneSpec
High-Sensitivity MAPPs for Immunogenicity Risk Assessment of Biotherapeutics
ImmunoPrecise Antibodies Ltd. (IPA)
Advancing Bispecific Lead Generation Through Integrated In Vivo and In Silico Approaches to Drive Clinical Success
ImmunoPrecise Antibodies Ltd. (IPA)
AI-Driven Development of pH-Selective Antibodies Targeting Human FOLR2 for Tumor-Specific Therapy
ImmunXperts, a IQVIA Laboratories company
Development and Optimization of Cost-Effective Non-Human Primate In Vitro Assays for Immunogenicity Screening and Functional Evaluation of Immuno-Oncology Drug Candidates
ImmunXperts, a IQVIA Laboratories company
TPIPE, a Pipeline for the Identification and Functional Assessment of Therapeutic Cancer Vaccine Candidates
Imperial Collage London
Collagen Targeting IL-12 Combined with Doxorubicin Enhances the Anti-Tumour Effect Against Osteosarcoma
Indian Institute of Technology Delhi
From Target Identification Using Bioinformatics to a Novel Therapeutic Candidate Antibody Targeting CD167a
INFORS HT
21x Increase in Plasmid Production Yield Compared to Traditional Methods
Institute for Protein Innovation
A Flexible Automated Workstation for our Antibody Discovery Pipeline
Institute for Protein Innovation
High Throughput Development of High-Affinity Fabs and VHH Using Minimalistic Libraries
Institute for Protein Innovation
High-Throughput Characterization and Validation of Reagent Antibody Tools for Neurexin-Neuroligin Receptor Families
Institute for Protein Innovation
High-Throughput Discovery of Recombinant Antibodies Against the Semaphorin Family
IntegerBio
Synthetic Interferon IB-001 Exhibits Potent Antiviral Activity Across both DNA and RNA Viruses with Limited Pro-Inflammatory Gene Induction
Integral Molecular
CDR-Scanning for Antibody Engineering and Patents: Comprehensive CDR Mutagenesis Identifies Residues for Improvements and Enables Antibody Genus Patent Claims
Integral Molecular
Off-Target Binding of Antibody-Based Biologics: A Systematic Evaluation of Drugs Throughout Clinical and Preclinical Development
Integral Molecular
Pan-Reactive MAbs Enable Preclinical Animal Models: MAbs for Validating Targets Across Diverse Animal Species
Invenra, Inc.
A Novel IgG-Like Trispecific Antibody Platform to Accelerate Lead Identification
Iontas Ltd.
Accelerating Antibody Discovery and Development into the Clinic with Mammalian Display
IQVIA Laboratories
H5N1 Pandemic Preparedness: Building a Comprehensive Immunological Toolbox
Isogenica Ltd.
Next Generation Conjugates – Site Specific Conjugation of VHH Antibody Modalities
JASCO Corporation
Higher-Order Structure Stability Assessment of Antibody-Drug Conjugate Using CD Spectroscopy
Johns Hopkins University
Biofloating: a workflow for the discovery of antibodies targeting multi-pass transmembrane proteins
Johns Hopkins University
Design of an Interleukin-2 Based Immunocytokine for Targeted Expansion of Muscle Regulatory T Cells
Johns Hopkins University
Mechanistic Insight into the Immunomodulatory Effects of a Potentiating Antibody Targeting the Interleukin-7 Cytokine
Johnson & Johnson Innovative Medicine
Click Chemistry-Driven Method Development for Antibody Conjugates
Just - Evotec Biologics
An Ultra High-Throughput Method to Generate a Large Conformational Thermostability Dataset via Phage-Display
KACTUS
GPCR VLPs & Nanodiscs for Drug Discovery
KACTUS
High-Performing GMP CRISPR Cas9 Protein for Cell and Gene Therapy
KACTUS
Transforming Tumor Research: Engineering MHCs as Versatile Reagents
Kaohsiung Medical University
Creating Tumor-Targeting Immune Checkpoint Inhibitors Using Interferon-Based Precursors to Enhance Anti-Cancer Potency and Reduce Systemic Side Effects
Kaohsiung Medical University
Encapsulation of Oxaliplatin by Exosomes Expressing Anti-EphA2 to Enhance the Therapeutic Effect of Pancreatic Cancer
Kaohsiung Medical University
Enhancing the Therapeutic Efficacy and Safety of Anti-CTLA4 Antibody in Colorectal Cancer with a Tumor-Activated Interferon Fusion Strategy
Kaohsiung Medical University
Maximizing Oxaliplatin’s Impact on EGFR+ Colorectal Cancer through Targeted Extracellular Vesicles
Kemp Proteins
Driving High Titer Production in HEK cells through Cell-line specific Optimization
KTH Royal Institute of Technology
Development of an Affibody Molecule for Monitoring Immune Cell Activation
KTH Royal Institute of Technology
Engineering of Affibody-Based Prodrugs for Cancer Therapy
LifeArc
Building Therapeutic Antibody Discovery Capabilities for Challenging Targets
LifeArc
Humanisation of a Mouse Anti-C6 Antibody as a Potential Therapeutic for Complement-Mediated Diseases
Lightcast
Advancing Antibody Discovery with Function-Focused Profiling at the Single-Cell Level
Lonza
Novel Synthetic Production Phase Promoter for Enhanced Titre, Product Quality and Expression Stability in CHO Cells
LUMICKS
Cell Avidity – The Next-Gen Cell Binding to Understand the Mechanism of Action Through Cell-Cell and Cell-Protein Interaction
Lxbio
A Novel Single-Cell Selection Platform for Rapid Identification of Antibodies Against Different Antigens from Breast Cancer Patients
Massachusetts Institute of Technology
Engineering TEV Protease Specificity with Machine Learning and a New Ultra-High-Throughput Assay
Matwings Technology
A General Temperature-Guided Language Model to Design Proteins of Enhanced Stability and Activity
Matwings Technology
Discovery of Expression-Governing Residues in Proteins
Matwings Technology
Immunogenicity Prediction with Dual Attention Enables Vaccine Target Selection
Mayo Clinic
Antibody-Based Therapeutics for the Treatment of Anti-Platelet Factor 4 (PF4)-Mediated Thrombotic Syndromes
MD Anderson Cancer Center
MIL33B, Anti-B7-H3 (CD276) Antibody Platform Expansion: FAS and PTD
Merck & Co., Inc.
A Data Platform and AI/ML-Driven Strategy to Accelerate Next-Generation Sequencing Analysis in Phage/Yeast Display
Merck & Co., Inc.
Accelerating Antibody Screening and Engineering with Automated High-Throughput Production Solutions and AI/ML-Driven Protein Design
Merck & Co., Inc.
High Diversity Phage Display Library for Discovery of High-Affinity VHH
Merck & Co., Inc.
Modulating TREM2-Dependent Signaling via Clustering Using Novel VHs
Merck & Co., Inc.
Purification, and Characterization of Lumazine Synthase Nanoparticles in Mammalian Cell Line
Merck & Co., Inc.
Robust High-Throughput Sample Preparation for Early Discovery Protein Characterization
Merck & Co., Inc.
Sequence Diversity of Antibody Display Library Identified Through Multiple In-Parallel NGS-Based Phage Pannings
Miltenyi Biotec B.V. & Co. KG
MACS Matchmaker: Biomolecular Interaction Analysis in Real Samples Label-Free, in Real-Time – Here Comes Focal Molography
ModeX Therapeutics
EPITOP™ / IMMUNOTOP™: Machine Learning Tools for Predicting Immunogenic Epitopes and Protein Immunogenicity
Nanite, Inc.
Durable but Transient Expression of Therapeutic Proteins In Vivo from Plasmid DNA
NanoTag Biotechnologies GmbH
The ALFA System: One Tag – Three sdAbs – Unlimited Applications
NEC Oncoimmunity - a NEC Bio company
Deep Learning of Antibody Epitopes Using Positional Permutation Vectors
NeoMab Biotechnology (Suzhou) Co., Ltd.
Development of Fully Human CD3 Antibodies and CD3/DLL3 TCEs with Potent Cytotoxicity and Reduced Cytokine Release
NeoMab Biotechnology (Suzhou) Co., Ltd.
Development of Fully Human CD98hc Antibodies to Enhance Delivery of Therapeutic Drugs Across the Blood-Brain Barrier
New England Biolabs, Inc.
Glycan Removal from Therapeutic Glycoproteins for Peptide and Intact Mass Analysis Using Rapid PNGase F, Protein Deglycosylation Mix II and Exoglycosidases
New England Biolabs, Inc.
Introducing NEBExpress® Salt Active Nuclease for Nucleic Acid Removal in Purification Workflows
New England Biolabs, Inc.
Rapid DIY Gene Synthesis: From Oligos to Low-Cost Genes with NEBridge® Golden Gate Assembly
Nexus BioQuest
A Human In Vitro Secondary Lymphoid Organ Model to Advance Immune-Modulatory Drug Development
Nicoya
Identification of Anti-Idiotype Antibodies Using Digital SPR
Nomic Bio
Where Did My Target Go? High-Throughput Plasma Proteomics of Checkpoint Inhibitor Therapy Reveals Regulation of Other Immunotherapy Targets
Nona Biosciences
Developing a Fully Human CD19 T Cell Engager Using NonaHCAbFx Platform
Novo Nordisk A/S
Decoding Antibody Behavior: Protein Language Models vs. Traditional Biophysical Parameters for Predicting Non-Specificity
Nuclera
Functional Membrane Proteins - Ready in 48 Hours
Nuclera
Increasing Soluble Protein Yield: Utilizing AlphaFold for Guided Protein Variant Design and Screening
NUMAFERM GmbH
Numaswitch – A Novel Biochemical Platform for Efficient Peptide and Protein Production
OCMS Bio
Enabling De Novo Antibody Discovery from AI-Designed Libraries
Odyssey Therapeutics
Discovery of a Best-in-Class Bispecific TRAILR2 Agonist for Treatment of Gastrointestinal Tumors
Ordaos Bio
Machine Learning-Driven VHH Design: From Sequence to Binding Data in 5 Days
PAIA Biotech GmbH
High Throughput Hydrophobicity and Polyreactivity Assays for 6His-Tagged Proteins
PAIA Biotech GmbH
Integration of a pH-Dependent FcRn Binding Assay into a Suite of Microplate-Based Developability Assays in High-Throughput
Partillion Bioscience
Beyond Binding: High-Throughput Functional Screening of Antibody Libraries via Flow Cytometry and Nanovials
Pharma Foods International Co., Ltd.
ALAgene® Technology: Harnessing Chicken Immunity to Generate High-Affinity, Cross-Reactive Antibodies Against Difficult Targets
Phenomenex, Inc.
Native RPLC-HRMS Method Development Approach for the Rapid Characterization of Antibody Drug Conjugates
Precision BioTools
Targeting KRAS Mutation Diversity with Epivolve®: A Novel Approach for Precision Cancer Therapeutics and Diagnostics
Primrose Bio
Pfenex Expression Technology® - Scalable Rapid Expression and Affinity Enrichment of Untagged RNA Polymerase Variants from Microtiter Plates
ProBio, Inc.
The Discovery and Development of a CD3 Agonistic Single Domain Antibody to Accelerate the Development of CD3 T Cell Engager Multi-Specific Antibodies
ProBioGen AG
Directed Luck®: Transposase Targeting and Transposon Design Push Expression Beyond Limits
ProImmune
ANKYRONS - Next Generation Target Binding and Detection
Promega Corporation
Development of Novel Luminescent Assays for Sensitive and Specific Quantitation of Double-Stranded RNA in mRNA Therapeutics
Promega Corporation
HiBiT Targeted Cell Killing (TCK) Bioassays for Biologics Characterization and Potency Testing
Promega Corporation
High-Sensitivity Lumit® IgG Titer Assays for Enhanced Quantification and Broad IgG Subclass Detection
Promega Corporation
Luminescent Fc Gamma Receptor Assays for ADCP and ADCC Characterization to Guide the Development of Antibody Therapeutics
Protein Metrics
Advancements in Multi-Protein Quantitation for Host Cell Protein Discovery
Protein Metrics
Orthogonal Techniques for LCMS Characterization of a Lysine-Conjugated ADC
PROTEINA
High-Throughput Antibody Engineering via Deep Mutational Scanning and Single-Molecule Fluorescence Imaging for Affinity and Developability Optimization
ProteoGenix
XtenCHO™ Race: High Performance CHO Cells for the Development and Production of New Therapeutic Antibodies
ProtiFi LLC
Standardized Tools for Biologics Analyses and QC: glyPAQ™ and the Turbo MAM Kits
PUXANO
Synergizing Protein Diffusion Models and Cryo-EM Innovations: Tackling Beta-Barrel Solubilization via Protein Engineering
Quantitative BioSciences, Inc.
Rapid, Animal-Free Discovery of Single-Domain Antibodies from a Novel Synthetic Library
Radiant Biotherapeutics, Inc.
Engineering the Next Generation of Antibody Therapeutics Using the Multabody Platform
RedShiftBio
Determining Protein Stability and Structure in One Measurement Using Microfluidic Modulation Spectroscopy (MMS)
Roche Diagnostics GmbH
Diligent Design of Brainshuttle™-ASO Conjugates Enables Peripheral Drug Delivery to the Brain
Salipro Biotech AB
Discovery and Characterization of Antibodies Against Challenging Membrane Protein Targets Using Salipro Nano-Membrane Particles
Sandia National Laboratories
Nanobody Hot Spot Residue Identification and Epitope Binning with AI Structural Prediction
Schrödinger, Inc.
Robust Physics-Based Methods for Accurate In Silico Prediction of pH-Dependent Protein-Protein Binding Affinities
Seismic Therapeutic
Enabling De Novo Antibody Design by Integrating ML-Based Sequence Generation with B Cell Epitope Prediction
Seismic Therapeutic
Integrating Machine Learning Based Antibody Sequence Generation with Yeast Display Enables High Success Rates of Multi-Objective Drug Design
Seismic Therapeutic
Utilizing IMPACT Platform to Engineer Selectivity of Biotherapeutics for Treatment of Autoimmune Diseases
Shanghai HongCheng Biopharma
HC029: A Conformation Selective Integrin β6 ADC
Slingshot Biosciences
Single Biomarker Cell Mimics for Standardized Monitoring of T-Cell Activation and Exhaustion in Antibody Drug Development
Smartfreez
Freeze-Thaw Induced mAb Aggregation: A Small-Volume Approach to Simulate Manufacturing
Sookmyung Women's University
Creating Innovative Biological Platforms to Develop Novel Therapies
Sphere Bio
Cyto-Mine Chroma: Accelerating Single-Cell Analysis and Sorting Using Multi-Laser Picodroplet Technology
Spheryx, Inc.
Filling Efficiency Measurements for Gene Therapies Using Total Holographic Characterization
SPOC Proteomics
Synthesizing Single-Chain Antibody Libraries Directly on SPOC SPR Biosensor Chips, to Generate High Resolution Kinetic Data at Scale, to Support AI-Drug Design and Affinity Maturation Cycles
Synaffix BV
Highly Potent, Bispecific ADCs by Application of Clinical Stage GlycoConnect® Technology to bYlok® Antibodies
Synaffix BV
proPBD-ADCs: Optimization of Therapeutic Potential of ADCs Based on Capped PBD Payload with Attenuated Potency
TA Instruments
Enhancing Protein Stability: The Role of Thermal Analysis in Formulation
Takeda Pharmaceuticals
Antibody Screening Strategies for Lead Identification to Evaluate Inflammatory Pathway Inhibition
Takeda Pharmaceuticals
Discovery of Anti-SAR2-COV2 XBB.1.5 and JN.1 Variant-Specific Monoclonal Single Domain Antibodies from a Synthetic sdAb Library
Tata Consultancy Services
A Novel Deep Learning Approach for Predicting Stability of Proteins upon Single Point Mutations
Telix Pharmaceuticals
ImmunoPET for the Detection of Nectin-4 and TROP2 in Bladder Cancer
TenSixty Bio
Development of a Novel ADC in Lung Cancer Leveraging a Multiomic Target Discovery Platform
Texas A&M University
Macrocyclization and Genetic Code Expansion of Phage-Displayed Peptide Libraries
Thermo Fisher Scientific
Automation of the Expi293™ PRO Expression System for High Titer, High Throughput Protein Production at the 96 Well Scale
Thermo Fisher Scientific
Expi293™ PRO Expression System: A Next-Generation Expression System for Higher Yields Across a Wider Variety of Proteins
Thermo Fisher Scientific
Expi293™ PRO Expression System: Expression Improvements Across Different Classes of Proteins, Product Quality Assessment and Purification Compatibility
Thermo Fisher Scientific
High-Throughput Methods for Monitoring Antibody Internalization and Lysosomal Degradation Using a Cathepsin-Activated Sensor and Site-Specific Conjugation
Thermo Fisher Scientific
Increasing Protein Titer and Achieving Consistent Product Quality in CHO Cells with a Novel Protein-Free Feed System
Thermo Fisher Scientific
Power Meets Precision | HTP Antibody Production with Expi™ Protein Expression Systems & GeneArt HTP Antibody Production
Thomson Instrument Company
New Mid-Scale Workflows for 20mL - 50mL in Automation Friendly Format
Thomson Instrument Company
Scalable Results 30mL-2L in Optimum Growth Flasks with ExpiCHO® After Transfection
Thomson Instrument Company
Thomson 7L Flask Replacing Bioreactor and Cell Bags Between 5L to 6L/Flask - Ability to Grow Up to 35L/Shaker
Tokyo Ohka Kogyo Co., Ltd.
SIEVEWELL: High Throughput Secretion Based Single Cell Screening for Antibody Discovery
Triveni Bio
TRIV-573, a Bispecific Antibody Combining KLK5/KLK7 and IL-13 Inhibition to Rebalance Barrier Dysfunction and Inflammation in Atopic Dermatitis
Tufts University
Chemotherapy Induces Pro-Invasive Changes in the Extracellular Matrix Produced by Mammary Fibroblasts
Twist Bioscience
Antibody Discovery from Immune VHH Library Using Yeast Surface Display
Twist Bioscience
Rapid Discovery of Hundreds of Rabbit mAbs with High Affinity and Cell Binding Against CD19 Utilizing the Beacon Optofluidic Platform
Twist Bioscience
VHH Antibody Discovery Leveraged by Synthetic DNA Technologies
University of Alabama at Birmingham
Development of Next-Generation Theranostics by De Novo Protein Design
University of Alabama at Birmingham
Synthetic Nanobody Library Design and Pharmacodynamic Selection Strategies for Novel Radiopharmaceuticals
University of Cambridge
Automated Optimisation of Solubility and Conformational Stability of Proteins
University of Cambridge
Mesothelin-Targeted Nanobody-Drug Conjugates to Treat Pancreatic Cancer
University of Cambridge
Non-Specificity Fingerprints for Clinical Stage Antibodies in Solution
University of Cambridge
Prediction of Protein Biophysical Traits from Limited Data: A Case Study on Nanobody Thermostability Through NanoMelt
University of Copenhagen
Clinical Potential of Oncofetal-Chondroitin Sulfate for Pan-Cancer VartumAb Antibody-Drug Conjugate Therapy
University of Edinburgh
Maxitope - Revolutionising Antigen Design
University of Lisbon
Development of Degrader-Antibody Conjugates for Triple-Negative Breast Cancer
University of Michigan
Generation of S100A8/A9 Nanobodies Using Directed Evolution
University of Michigan
IKS04: A Novel CanAg-Targeting Antibody-Drug Conjugate with Pyrrolobenzodiazepine (PBD) Prodrug Payload, Shows Enhanced Efficacy with Isumab04 Antibody Coadministration in Preclinical Models
University of Michigan
Pharmacokinetic Characterization of Brain Delivery Using Bispecific Antibodies Targeting CD98hc and Transferrin Receptor
University of Oregon
Accelerating Therapeutics Discovery: Expressing Human Proteome and Screening Binders in E. coli
University of Oxford
LICHEN: Light-Chain Immunoglobulin Sequence Generation Conditioned on the Heavy Chain and Experimental Needs
University of Oxford
Predicting the Developability of Nanobodies to Improve Therapeutic Design
University of Texas at Austin
Antibody Therapeutics Targeting the Neuropilin-1 Receptor Domain of VEGFA & PlGF2: New Tools to Parse Cancer Angiogenesis
University of Texas at Austin
Structure-Guided Fc Engineering for Cross-Species FcgR Binding
University of Texas at Austin
Towards Better Therapeutics: Evaluating Computationally Humanized Antibodies
University of Texas Rio Grande Valley
scFvs: Targeting Snake Venom Phospholipase A2 and Serine Protease
University of Utah
Deep Mutational Scanning of VRC01 HIV Broadly Neutralizing Antibody Reveals Potential Pathways of HIV Env N276 Glycan Accommodation
University of Warsaw
Reliable In Silico T Cell Activation Prediction for Neoantigens Close to Self-Peptidome
Vaccinex, Inc.
Antibody Discovery for Complex Membrane Antigens
Van Andel Institute
CoCUT&Tag Maps the Physical Association of Multiple Proteins on the Genome at a Single-Molecule and Single-Cell Resolution
Vazyme Biotech Co., Ltd.
Innovative Assays and Kits for Antibody Drug Development
Velavigo (Shanghai) Ltd.
VTS118-TriAb for Severe SLE and Other B Cells or Autoantibody Associated Severe Autoimmune Diseases
Visterra, Inc.
Investigating Single-Cell Foundation Models for Drug Target Prioritization
Washington University
Re-Engineering SARS-CoV-2 Antibodies Using a Supervised Machine Learning Approach
Waters Corporation
High Sensitivity Titer & 2D Protein A-SEC Analysis for Faster Quantitation of mAb Titers and Aggregates
WuXi Biologics
Micro Developability: High-Throughput Developability Assessment for Early-Stage Lead Optimization
WuXi Biologics
TFC Quick ‘n’ Clean: Next-Gen Platform for High-Throughput Production of True Four-Chain BsAbs
WuXi XDC
An Integrated Approach to Accelerate the ADC Discovery with WuXi XDC Innovative Technology Toolbox
Wyatt Technology
Novel Light Scattering Methods for Accelerating the Development of ADCs
XTOP Biotherapeutics LLC
CrossBody: An Innovative Multispecific Antibody Platform to Overcome On-target, Off-Tumor and Cytokine Release Syndrome Toxicity
Yale University
High-Throughput Identification and Characterization of Patient-Derived Monoclonal Autoantibodies in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Yurogen Biosystems
Development of Rabbit Anti-Polyethylene Glycol (PEG) Monoclonal Antibodies for Pharmacokinetic Studies of PEGylated Drugs
Yurogen Biosystems
Enhancing Antibody Discovery Single-Cell Immune Repertoire Sequencing and Artificial Intelligence
Zonsen Peplib Biotech
Peptide Radioligand Development via PepLib’s Advanced Peptide Discovery Platform